Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids’, men’s, and women’s care products. The company also offers prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardiovascular system, dermatology, diabetes, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology. In addition, it provides logistical and marketing services for the sale of goods manufactured by third parties, social enterprise, and wellness center, as well as involved in the software design, development, and other services business. The company was incorporated in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited operates as a subsidiary of Unistretch Limited.
Metrics to compare | MEGA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEGAPeersSector | |
---|---|---|---|---|
P/E Ratio | 13.9x | 23.5x | −0.6x | |
PEG Ratio | −2.04 | −0.66 | 0.00 | |
Price/Book | 2.6x | 1.9x | 2.6x | |
Price / LTM Sales | 1.8x | 2.2x | 3.3x | |
Upside (Analyst Target) | 10.9% | 21.6% | 39.1% | |
Fair Value Upside | Unlock | 12.7% | 4.5% | Unlock |